# Cumberland Pharmaceuticals Inc: Form 8-K, filed Sep 6, 2023

- Company: [Cumberland Pharmaceuticals Inc](/companies/cpix.md) (CIK 1087294)
- Form: 8-K
- Filed: 2023-09-06
- Accepted by EDGAR: Sep 5, 2023, 19:56 ET
- Period: 2023-09-05
- Accession: 0001628280-23-031458
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1087294/000162828023031458/cpix-20230905.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1087294/000162828023031458/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1087294/000162828023031458/cpix-20230905.htm

Filed Sep 6, 2023.
Source: SEC EDGAR, the filing index for accession 0001628280-23-031458. Last ingested by Listed: Oct 26, 2026, 16:41 ET. No prices; not investment advice.